CUSIP: 86882L113
Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / *W EXP 10/22/202
-
Total 13F shares
-
1,045,115
-
Share change
-
-469,792
-
Total reported value
-
$411,694
-
Price per share
-
$0.27
-
Number of holders
-
9
-
Value change
-
-$142,075
-
Number of buys
-
1
-
Number of sells
-
4
Quarterly Holders Quick Answers
What is CUSIP 86882L113?
CUSIP 86882L113 identifies SURGW - SURGEPAYS INC - *W EXP 10/22/202 in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2024
-
Previous quarter:
Q1 2024
Recent filing periods for CUSIP 86882L113:
Institutional Holders of SURGEPAYS INC - *W EXP 10/22/202 (SURGW) as of Q2 2024
As of 30 Jun 2024,
SURGEPAYS INC - *W EXP 10/22/202 (SURGW) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,045,115 shares.
The largest 9 holders included
Warberg Asset Management LLC, Privium Fund Management B.V., CVI Holdings, LLC, Cruiser Capital Advisors, LLC, BOOTHBAY FUND MANAGEMENT, LLC, Miracle Mile Advisors, LLC, Connective Capital Management, LLC, JPMORGAN CHASE & CO, and UBS Group AG.
This page lists
9
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.